132 related articles for article (PubMed ID: 11268989)
1. Prognostic factors in early gastric cancer.
Kunisaki C; Shimada H; Takahashi M; Ookubo K; Moriwaki Y; Akiyama H; Nomura M
Hepatogastroenterology; 2001; 48(37):294-8. PubMed ID: 11268989
[TBL] [Abstract][Full Text] [Related]
2. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
3. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
Wu CY; Chen JT; Chen GH; Yeh HZ
Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
[TBL] [Abstract][Full Text] [Related]
11. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
12. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
Maehara Y; Tomoda M; Hasuda S; Kabashima A; Tokunaga E; Kakeji Y; Sugimachi K
Br J Cancer; 1999 Mar; 79(7-8):1255-61. PubMed ID: 10098768
[TBL] [Abstract][Full Text] [Related]
16. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
17. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival time after curative surgery for advanced gastric cancer.
Moriguchi S; Maehara Y; Korenaga D; Sugimachi K; Hayashi Y; Nose Y
Eur J Surg Oncol; 1992 Jun; 18(3):287-92. PubMed ID: 1607042
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of early recurrent death after a curative resection of gastric cancer.
Mikami K; Maekawa T; Shinohara T; Hoshino S; Yamauchi Y; Noritomi T; Yamashita Y
Int Surg; 2009; 94(2):144-8. PubMed ID: 20108618
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]